After seeding of huPBMCs and γ‐retrovirus, upon subcutaneous implantation, MASTER served as a bioinstructive factory permitting CD19‐CAR‐T generation and expansion, resulting in the release of CAR‐Ts into the bloodstream, further suppressing distal tumor growth in a mouse xenograft model of lymphoma. Here, CD19 is linked to neoplasm.